<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" bill-type="olc" dms-id="A1" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>116 S2354 IS: Expanding Findings for Federal Opioid Research and Treatment Act</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2019-07-31</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">II</distribution-code><congress>116th CONGRESS</congress><session>1st Session</session><legis-num>S. 2354</legis-num><current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber><action><action-date date="20190731">July 31, 2019</action-date><action-desc><sponsor name-id="S337">Mr. Coons</sponsor> (for himself and <cosponsor name-id="S377">Mr. Gardner</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSCM00">Committee on Commerce, Science, and Transportation</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title>To direct the Director of the National Science Foundation to support research on opioid addiction,
			 and for other purposes.</official-title></form>
	<legis-body display-enacting-clause="yes-display-enacting-clause" id="HD2188BCB94E04991901C60122C9400A8" style="OLC">
		<section id="H74155FBEF8504219897A999B3649FCAF" section-type="section-one"><enum>1.</enum><header>Short title; findings</header>
 <subsection id="H93C580B1015A4A93B49867334D83EE3B"><enum>(a)</enum><header>Short title</header><text display-inline="yes-display-inline">This Act may be cited as the <quote><short-title>Expanding Findings for Federal Opioid Research and Treatment Act</short-title></quote> or the <quote><short-title>EFFORT Act</short-title></quote>.</text> </subsection><subsection id="H31E1F489D2BC429F901C65BF28597744"><enum>(b)</enum><header>Findings</header><text>The Congress finds that—</text>
 <paragraph id="HC93036AC74D240939BC5CE49FCBFE682"><enum>(1)</enum><text display-inline="yes-display-inline">research gaps currently exist in the prevention and treatment of opioid addiction;</text> </paragraph><paragraph id="H7552AB51DA4D4F5492A3873B1FAFD496"><enum>(2)</enum><text display-inline="yes-display-inline">the National Science Foundation’s research on opioid addiction has increased understanding of the neuroscience of addiction, substance abuse intervention, the role of illicit supply networks, the secondary effects on families, the use of technology to address the opioid epidemic, and options for alternative, non-addictive therapeutics for pain; and</text>
 </paragraph><paragraph id="HB4568F012AEA46B6877AD62DD994DB7D"><enum>(3)</enum><text>the National Science Foundation and the National Institutes of Health have recognized that fundamental questions in basic, clinical, and translational research would benefit greatly from multidisciplinary approaches and collaboration.</text>
 </paragraph></subsection></section><section id="H9735136F671C4C1991352FC6F907EF8E"><enum>2.</enum><header>NSF support of research on opioid addiction</header><text display-inline="no-display-inline">The Director of the National Science Foundation, in consultation with the Director of the National Institutes of Health, shall support merit-reviewed and competitively awarded research on the science of opioid addiction.</text></section></legis-body></bill>


